{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-415730","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2026-10-06T20:57:49+00:00","discovered_at":"2026-10-06T20:59:00.246189+00:00","generated_at":"2026-10-12T16:10:51.608791+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Quince Therapeutics stockholders approve 2026 equity plans, charter amendment, and Series C conversion proposals","bullets":["Stockholders approved the 2026 Equity Incentive Plan with an initial reserve of 821,872 shares plus up to 1,377,845 returning shares, and the 2026 ESPP with 142,045 shares.","The charter amendment increased authorized common stock from 250,000,000 to 275,000,000 shares and was filed in Delaware on Oct. 6, 2026.","At the Oct. 6, 2026 special meeting, 611,465 of 1,017,063 outstanding shares, or 60%, were present; all five presented proposals were approved.","Proposal 1, covering Series C preferred conversion and warrants/options, was approved 180,550 to 5,742, with 162,971 shares excluded; it may result in a change of control under Nasdaq Rule 5635(b).","The 2026 Plan reserve automatically increases 5% annually from Jan. 1, 2027 through Jan. 1, 2036; the ESPP increases by the lesser of 1% or two times its initial reserve."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-415730","json":"https://secwatch.observer/filing/0001193125-26-415730.json","markdown":"https://secwatch.observer/filing/0001193125-26-415730.md","text":"https://secwatch.observer/filing/0001193125-26-415730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526415730/0001193125-26-415730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526415730/d115238d8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:10:51.608791+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}